(insulin aspart + insulin aspart protamine)
Marketedupdated 2mo agoby Novo Nordisk Inc
Approvedcommunity read0 votes
indications
investigational
Type 2 Diabetes
all catalysts(1)
phase 3 initiation · 1
News(0)
no news has mentioned this drug yet
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that